Search

Search Constraints

You searched for: Author/Creator Vergara, Julie

Search Results

1. A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA–SE) in healthy adults. Issue 7 (11th February 2020)

2. A structure‐function approach to optimizing TLR4 ligands for human vaccines. Issue 11 (2nd November 2016)

3. From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH‐F3+GLA‐SE. Issue 4 (10th April 2015)

4. Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. Issue 4 (April 2021)

5. Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. Issue 4 (April 2021)

6. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial. Issue 4 (April 2018)

7. Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis. Issue 25 (27th May 2016)